Investigating Public Awareness About the Effect of Over-the-Counter Drugs on the Heart in Benghazi City, Libya
DOI:
https://doi.org/10.54361/LJMR.20.1.14Keywords:
over-the-counter drugs, . nonsteroidal anti-inflammatory drugs (NSAIDs), Heart, Cardiovascular effectAbstract
Background: Over-the-counter (OTC) medications are widely used for self-treatment without medical supervision. While considered generally safe, some OTCs— such as nonsteroidal anti-inflammatory drugs (NSAIDs), decongestants, and certain pain relievers — have been associated with adverse cardiovascular effects, including hypertension, arrhythmias, and increased risk of heart attacks. Despite this, public awareness about these risks remains limited, especially in developing countries like Libya, where regulation and health education are often insufficient. Benghazi, as a major city, presents an important context for assessing such awareness. Aim: To assess the awareness of the public of Benghazi about the effect of OTCs on heart health. Methods: This descriptive cross-sectional study is composed of two main sections: Section A – Pharmacist Survey: A short Google Forms questionnaire consisting of four questions was distributed among pharmacists to identify the most commonly dispensed OTCs and understand local usage trends. The same data collection period and analysis methods were applied as in Section B.– Public Survey: A structured online questionnaire was shared via social media platforms to assess public knowledge, behaviors, and attitudes concerning the use of OTCs and their cardiovascular impact in Benghazi. Sample Size: 385 participants (determined using Cochran’s formula). Exclusion Criteria: Medical doctors, medical students, and individuals with cardiac conditions. Data Analysis: Descriptive statistics and reliability testing using SPSS.Results: 328 participants completed the survey and were included in the present analysis. 53.9% of the participants were female, with the majority (34.2%) aged between 21 and 30 years old. Additionally, 85.6% attended university, 20.7% reported having chronic diseases. Conclusion: The findings of this study are consistent with both local and international research, highlighting the critical need to bridge the gap between awareness and behaviour. Comprehensive educational initiatives and regulatory improvements are essential to reduce cardiovascular and systemic risks associated with inappropriate OTC medication use
Downloads
References
1. Research C for DE and. Over-the-Counter OTC | Nonprescription Drugs. FDA. Published May 18, 2020. https://www.fda.gov/drugs/how-drugs-are-developed-and-approved/over-counter-otc-nonprescription-drugs
2. Westerlund, T., Barzi, S., Bernsten, C.. (2017), Consumer views on safety of over-the-counter drugs, preferred retailers and information sources in Sweden: after re-regulation of the pharmacy market. Pharmacy Practice. 15(1), 1-8DOI:
3. Goyal A, Gaur A, Chhabra M, Deepak K. Knowledge, Attitude and Practices of over the Counter (OTC) Medicines among rural Population - A Cross Sectional Study. Asian Journal of Pharmacy and Pharmacology.;4(2):227-231. doi: https://doi.org/10.31024/ajpp.2018.4.2.21
4. Center for Drug Evaluation and Research. Understanding Over-the-Counter Medicines. FDA. Published August 14, 2019. https://www.fda.gov/drugs/buying-using-medicine-safely/understanding-over-counter-medicines
5. Over-the-Counter Medicines. Medlineplus.gov. Published 2019. https://medlineplus.gov/overthecountermedicines.html
6. Aloudah, N., Alhumsi, A., Alobeid, N., Aboheimed, N., Aboheimed, H., Aboheimed, G. (2020), Factors impeding the supply of over-the-counter medications according to evidence-based practice: A mixed-methods study. Schneider CR, ed. PLOS ONE. 15(11):e0240913. DOI: https://doi.org/10.1371/journal.pone.0240913
7. Sánchez-Sánchez, E., Fernández-Cerezo, F.L., Díaz-Jimenez, J., et al. (2021). Consumption of over-the-Counter drugs: Prevalence and type of drugs. International Journal of Environmental Research and Public Health. 18(11): 5530. DOI: https://doi.org/10.3390/ijerph18115530
8. Alshahrani, S.M., Alakhali, K.M., Al-Worafi ,Y.M, et al. (2020)A. Awareness and use of over the counter analgesic medication: A survey in the Aseer region population, Saudi Arabia. International Journal of Advanced and applied sciences. 7(3):130-134. DOI: https://doi.org/10.21833/ijaas.2020.03.015
9. Brabers, A.E.M., Van Dijk, L., Bouvy, M.L., De Jong, J.D., (2020), Where to buy OTC medications? A cross-sectional survey investigating consumers’ confidence in over-the-counter (OTC) skills and their attitudes towards the availability of OTC painkillers. BMJ Open. 2013;3(9):e003455. doi: https://doi.org/10.1136/bmjopen-2013-003455
10. Fendrick, A.M., Pan, D.E., Johnson, G.E., (2008), OTC analgesics and drug interactions: clinical implications. Osteopathic Medicine and Primary Care. 2(1). DOI: https://doi.org/10.1186/1750-4732-2-2
11. Scheiman, J.M., Fendrick, A.M., (2005), Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs. Arthritis Research & Therapy. 7(Suppl 4):S23. DOI: https://doi.org/10.1186/ar1795
12. Ruschitzka, F., Borer, J.S., Krum, H., et al., (2017), Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. European Heart Journal. 38(44): 3282-3292. DOI: https://doi.org/10.1093/eurheartj/ehx508
13. Koffeman, A.R., Valkhoff, V.E., Çelik, S., et al. (2014), High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study. British Journal of General Practice. 64(621): e191-e198. DOI: https://doi.org/10.3399/bjgp14x677815
14. Trelle, S., Reichenbach, S., Wandel, S., et al. (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 342(jan11 1): c7086-c7086. DOI: https://doi.org/10.1136/bmj.c7086
15. Ghlichloo I, Gerriets V. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547742/
16. Wongrakpanich, S., Wongrakpanich, A., Melhado, K., Rangaswami, J., (2018), A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging and Disease. 9(1):143-150. DOI: 10.14336/AD.2017.0306
17. García Rodríguez, L.A., González-Pérez, A., Bueno, H., Hwa, J., (2011), NSAID Use Selectively Increases the Risk of Non-Fatal Myocardial Infarction: A Systematic Review of Randomised Trials and Observational Studies. Ross J, ed. PLoS ONE. 6(2):e16780. DOI: https://doi.org/10.1371/journal.pone.0016780
18. Fanelli, A., Ghisi, D., Aprile, P.L., Lapi, F., (2017), Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications. Therapeutic Advances in Drug Safety. 8(6):173-182. DOI: https://doi.org/10.1177/2042098617690485
19. Hippisley-Cox, J., Coupland, C., (2005), Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ. 330(7504):1366. DOI: https://doi.org/10.1136/bmj.330.7504.1366
20. García Rodríguez, L. A., González-Pérez, A. (2005). Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC medicine, 3(17): 1-6. DOI: 10.1186/1741-7015-3-17
21. McGettigan, P., Henry, D., (2013), Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries. Turnbull FM, ed. PLoS Medicine.10(2):e1001388. DOI: https://doi.org/10.1371/journal.pmed.1001388
22. British Heart Foundation. Ibuprofen and heart failure. Bhf.org.uk. Published November 2019. https://www.bhf.org.uk/informationsupport/heart-matters-magazine/news/behind-the-headlines/ibuprofen-and-heart-failure
23. Singh, G., Wu, O., Langhorne, P., Madhok, R., (2006), Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Research & Therapy.8(5):R153. doi:https://doi.org/10.1186/ar2047
24. Grosser, T., Fries, S., FitzGerald, G. A. (2006). Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. The Journal of clinical investigation, 116(1), 4–15. DOI: 10.1172/JCI27291
25. Shampe, R., Gdara, A., Gdara, A., Hefzy, S., (2024), Awareness Assessment of Over-The-Counter Analgesics among Zawia University Students, Libya. Alq J Med App Sci. 7(4):1386-1392. DOI: https://doi.org/10.54361/ajmas.247467
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mohamed K. A. Elkawafi, Mahmoud A M Elmansourya, Zainab. O. Benamer, Sajeda. A .Al-Majbri, Rana Abdalmajeed, Nuha. A. El-Naas, Nouri Mumash (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
